Initiating Free Research Reports on UnitedHealth Group and Three Other Healthcare Equities
Stock Research Monitor: HUM, MOH, and RHE
LONDON, UK / ACCESSWIRE / June 21, 2018 / If you want a free Stock Review on UNH sign up now at www.wallstequities.com/registration. On Wednesday, benchmark US indices were mixed as the NASDAQ Composite closed the trading session up 0.72%; the Dow Jones Industrial Average edged 0.17% lower; and the S&P 500 was up 0.17%. US markets saw seven out of nine sectors finishing the day in green, one in red, and one in neutral territory. Pre-market today, WallStEquities.com reviews these four Healthcare stocks: Humana Inc. (HUM), Molina Healthcare Inc. (MOH), UnitedHealth Group Inc. (UNH), and Regional Health Properties Inc. (NYSE AMER: RHE). All you have to do is sign up today for this free limited time offer by clicking the link below.
www.wallstequities.com/registration
Humana
Louisville, Kentucky headquartered Humana Inc.'s stock finished Wednesday's session 0.15% higher at $300.25. A total volume of 370,260 shares was traded. The Company's shares have advanced 10.87% over the previous three months and 28.88% in the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 2.50% and 12.49%, respectively. Furthermore, shares of Humana, which together with its subsidiaries, operates as a health and well-being company in the US, have a Relative Strength Index (RSI) of 53.43.
On June 01st, 2018, research firm Citigroup resumed its 'Buy' rating on the Company's stock, with a target price of $340 per share. Get the full research report on HUM for free by clicking below at:
www.wallstequities.com/registration/?symbol=HUM
Molina Healthcare
Shares in Long Beach, California headquartered Molina Healthcare Inc. ended at $98.00, up 1.18% from the last trading session. The stock recorded a trading volume of 677,501 shares. The Company's shares have gained 13.33% in the last month, 25.18% over the previous three months, and 40.64% in the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 13.92% and 26.09%, respectively. Moreover, shares of Molina Healthcare, which provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the US, have an RSI of 76.95. Gain free access to the research report on MOH at:
www.wallstequities.com/registration/?symbol=MOH
UnitedHealth Group
Minnetonka, Minnesota-based UnitedHealth Group Inc.'s stock ended yesterday's session 0.08% lower at $252.81 with a total trading volume of 2.05 million shares. The Company's shares have advanced 13.46% over the previous three months and 37.94% in the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 5.13% and 13.40%, respectively. Additionally, shares of UnitedHealth Group, which operates as a diversified health care company in the US, have an RSI of 61.34.
On June 11th, 2018, research firm SunTrust initiated a 'Buy' rating on the Company's stock, with a target price of $300 per share. Signing up today on Wall St. Equities will give you access to the latest report on UNH at:
www.wallstequities.com/registration/?symbol=UNH
Regional Health Properties
On Wednesday, shares in Suwanee, Georgia headquartered Regional Health Properties Inc. recorded a trading volume of 120,598 shares. The stock finished the day 1.03% lower at $0.22. The stock is trading below its 50-day moving averages by 19.33%. Furthermore, shares of the Company, which through its subsidiaries, operates as a self-managed healthcare real estate investment company that invests primarily in real estate purposed for senior living and long-term healthcare through facility lease and sub-lease transaction, have an RSI of 43.35. Register now for today's free coverage on RHE at:
www.wallstequities.com/registration/?symbol=RHE
Wall St. Equities:
Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
WSE has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
NO WARRANTY
WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://wallstequities.com/legal-disclaimer/
CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: Wall St. Equities
